Logo
x

Search

Subscribe Now

EGFR-Mutated Non-Small Cell Lung Cancer

Eli Lilly Report Results of Cyramza (ramucirumab) in P-III RELAY Study for 1L Treatment of EGFR-Mutated Non-Small Cell Lung Cancer

Eli Lilly Report Results of Cyramza (ramucirumab) in P-III RELAY Study for 1L Treatment of EGFR-Mutated Non-Small Cell Lung Cancer

  • October 7, 2019
AstraZeneca's Tagrisso (osimertinib) Receives NMPA's Approval as a 1L Therapy for EGFR-Mutated Non-Small Cell Lung Cancer in China

AstraZeneca's Tagrisso (osimertinib) Receives NMPA's Approval as a 1L Therapy for EGFR-Mutated Non-Small Cell Lung Cancer in China

  • September 4, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.